DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Matulonis U, Shapira R, Santin A. et al.
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: Final results from the Phase 2 KEYNOTE-100 study. ASCO 2020.
J Clin Oncol 2020;
38 (15_Suppl): 6005
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.